Cargando…

Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma

BACKGROUND: Non-clear cell renal cell carcinoma (ccRCC) includes histologically and molecularly distinct subtypes such as papillary, chromophobe, collecting duct, and sarcomatoid RCC, with an incidence ranging from 20% to 25%. Oncologic outcomes and the role of adjuvant systemic therapy [vascular en...

Descripción completa

Detalles Bibliográficos
Autores principales:	An, Josiah, Packiam, Vignesh T., Chennamadhavuni, Adithya, Richards, Jordan, Jain, Jayanshu, Mott, Sarah L., Garje, Rohan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786111/ https://www.ncbi.nlm.nih.gov/pubmed/35083144 http://dx.doi.org/10.3389/fonc.2021.786307

Ejemplares similares

Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
por: Vikas, Praveen, et al.
Publicado: (2020)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies
por: Swami, Umang, et al.
Publicado: (2020)

The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma
por: Garje, Rohan, et al.
Publicado: (2020)

Metastatic Non-Clear Cell Renal Cell Carcinoma: An Evidence Based Review of Current Treatment Strategies
por: Sankin, Alexander, et al.
Publicado: (2015)

Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment
por: Garje, Rohan, et al.
Publicado: (2018)

Combined robotic radical prostatectomy and laparoscopic proctectomy for synchronous prostate and rectal cancer
por: Tully, Zachary, et al.
Publicado: (2022)

The role of immunotherapy in non-clear cell renal cell carcinoma
por: Climent, Carla, et al.
Publicado: (2023)

Circulating Tumor DNA in Identifying Resistant Sub-Clones Post EGFR Blockade: Implications for EGFR Rechallenge
por: Chennamadhavuni, Adithya, et al.
Publicado: (2022)

Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
por: Gu, Yufeng, et al.
Publicado: (2023)

Metastatic Clear Cell Renal Cell Carcinoma Presenting as Acute Appendicitis
por: Ushakova, Oxana, et al.
Publicado: (2023)

The emerging role of somatic tumor sequencing in the treatment of urothelial cancer
por: Wen, Lexiaochuan, et al.
Publicado: (2021)

Metastatic clear cell renal cell carcinoma to the forearm without identifiable primary renal mass
por: Walton, John, et al.
Publicado: (2019)

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
por: Evelönn, Emma Andersson, et al.
Publicado: (2019)

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
por: D'Aniello, Carmine, et al.
Publicado: (2019)

Association between diabetes mellitus and poor patient outcomes after out-of-hospital cardiac arrest: A systematic review and meta-analysis
por: Voruganti, Dinesh Chandra, et al.
Publicado: (2018)

Radiomics Analysis of Contrast-Enhanced CT Predicts Survival in Clear Cell Renal Cell Carcinoma
por: Yan, Lei, et al.
Publicado: (2021)

FMNL1 Exhibits Pro-Metastatic Activity via CXCR2 in Clear Cell Renal Cell Carcinoma
por: Zhang, Mei-Fang, et al.
Publicado: (2020)

Cutaneous Metastases and Long-Term Survival of a Patient With Clear Cell Renal Carcinoma
por: Vilaça, Marta, et al.
Publicado: (2022)

CT-based transformer model for non-invasively predicting the Fuhrman nuclear grade of clear cell renal cell carcinoma
por: Yang, Meiyi, et al.
Publicado: (2022)

STAM Prolongs Clear Cell Renal Cell Carcinoma Patients' Survival via Inhibiting Cell Growth and Invasion
por: Deng, Tuo, et al.
Publicado: (2021)

Differing Von Hippel Lindau Genotype in Paired Primary and Metastatic Tumors in Patients with Clear Cell Renal Cell Carcinoma
por: Vaziri, Susan A. J., et al.
Publicado: (2012)

Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation
por: An, Josiah, et al.
Publicado: (2021)

An Effective Hypoxia-Related Long Non-Coding RNAs Assessment Model for Prognosis of Clear Cell Renal Carcinoma
por: Zhang, Han, et al.
Publicado: (2021)

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019)

Cellular milieu in clear cell renal cell carcinoma
por: Raghubar, Arti M., et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database
por: Huang, Guangyi, et al.
Publicado: (2022)

A Novel Prognostic Model Based on Autophagy-Related Long Non-Coding RNAs for Clear Cell Renal Cell Carcinoma
por: Li, Xinyuan, et al.
Publicado: (2021)

Corrigendum: STAM Prolongs Clear Cell Renal Cell Carcinoma Patients’ Survival via Inhibiting Cell Growth and Invasion
por: Deng, Tuo, et al.
Publicado: (2021)

Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma
por: Chang, Kaili, et al.
Publicado: (2021)

Development and validation of a novel immunotype for prediction of overall survival in patients with clear cell renal cell carcinoma
por: Yu, Deshui, et al.
Publicado: (2022)

Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell Carcinomas
por: Shih, Andrew J., et al.
Publicado: (2020)

Predictors of Progression-Free Survival and Overall Survival in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Single-Center Experience
por: Barua, Sasanka Kumar, et al.
Publicado: (2019)

Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients
por: Yang, Huiying, et al.
Publicado: (2020)

The unexpected finding of a synchronous metastatic seminoma in para-aortic nodes excised in a case of clear cell renal cell carcinoma
por: Brewin, Anna, et al.
Publicado: (2020)

A Novel mRNA-miRNA Regulatory Sub-Network Associated With Prognosis of Metastatic Clear Cell Renal Cell Carcinoma
por: Yang, Tianyu, et al.
Publicado: (2021)

Consensus statements from the EAU-ESMO collaboration for advanced and variant bladder cancer: can we move the needle to improve survival?
por: Packiam, Vignesh T.
Publicado: (2020)

Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible
por: Frydenlund, Noah, et al.
Publicado: (2018)

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
por: Gu, Cheng-Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c8oma0ogers6fam33s3oemepb2